REQUEST A DEMO
Total
USD $0.00
Search more companies

Swixx Biopharma OU (Estonia)

Main Activities: Other Business Support Services
Full name: Swixx Biopharma OU Profile Updated: July 28, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Russian Download a sample report

Swixx Biopharma OU is an enterprise in Estonia, with the main office in Tallinn. It operates in the Other Business Support Services sector. Swixx Biopharma OU was incorporated on October 23, 2014. 25 (2024) employees currently work for Swixx Biopharma OU. There was a net sales revenue increase of 10.11% reported in Swixx Biopharma OU’s latest financial highlights for 2025. There was a total growth of 36.17% in Swixx Biopharma OU’s total assets over the same period. In 2025, Swixx Biopharma OU’s net profit margin increased by 2.69%.

Headquarters
Parnu mnt 139e/2 Kesklinna linnaosa
Tallinn; Harju county; Postal Code: 11317

Contact Details: Purchase the Swixx Biopharma OU report to view the information.

Basic Information
Total Employees:
Purchase the Swixx Biopharma OU report to view the information.
Registered Capital:
Purchase the Swixx Biopharma OU report to view the information.
Financial Auditors:
Purchase the Swixx Biopharma OU report to view the information.
Incorporation Date:
October 23, 2014
Key Executives
Purchase this report to view the information.
Member of Management Board
Purchase this report to view the information.
Member of Management Board
Purchase this report to view the information.
Member of Management Board
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Swixx Biopharma OU report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
10.11%
Total Operating Revenue
10.11%
Operating Profit
67.38%
EBITDA
64.22%
Net Profit/Loss for the Period
67.35%
Total Assets
36.17%
Total Equity
50.26%
Operating Profit Margin
2.68%
Net Profit Margin
2.69%
Return on Equity (ROE)
3.42%
Cash Ratio
-0.25%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?